Filing Flows › Core Scientific, Inc./tx (CORZ) › Q2 2026 › vs Q2 2025
Core Scientific, Inc./tx (CORZ) Q2 2026 vs Q2 2025 (year over year)
Core Scientific, Inc./tx's revenue rose $85.6M (+109%) from $78.6M in Q2 2025 to $164M in Q2 2026.
Core Scientific, Inc./tx, Q2 2026: revenue $164M (+109% year over year), operating margin -47.8%, net loss $1.2B, operating cash flow −$18.9M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $164M | $78.6M | $85.6M | +109% |
| Net loss | $1.2B | $937M | $219M | +23% |
| Costs & expenses | $1.3B | $1.0B | $304M | +30% |
| Operating costs | $243M | $105M | $138M | +131% |
| Interest & other, net | $1.1B | $910M | $165M | +18% |
| Income tax | $1.9M | $158K | $1.7M | 12× |
| Cost of revenue | $94.2M | $73.6M | $20.6M | +28% |
| Operating cash sources | $1.2B | $937M | $219M | +23% |
| Depreciation & amortization | $15.5M | $18.8M | −$3.3M | -17% |
| Share-based compensation | $18.2M | $24.2M | −$5.9M | -25% |
| Working capital & other | $1.1B | $928M | $175M | +19% |
| Cash used in operations | $18.9M | −$34.0M | $52.9M | — |
| Net loss absorbed | $1.2B | $937M | $219M | +23% |
Questions
How much did Core Scientific, Inc./tx's revenue grow year over year in Q2 2026?
Core Scientific, Inc./tx's revenue rose $85.6M (+109%) from $78.6M in Q2 2025 to $164M in Q2 2026.